What is involved in an Esophagogastroduodenoscopy (EGD) procedure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Essential EGD (Esophagogastroduodenoscopy) Knowledge

A high-quality EGD requires systematic examination from the upper esophageal sphincter to the distal duodenum with an average inspection time of at least 7 minutes, photo-documentation of 8 anatomical landmarks, and appropriate biopsies based on specific clinical indications. 1

Pre-Procedure Requirements

Patient Preparation:

  • Allocate minimum 20-minute time slots for standard diagnostic procedures, with longer slots for surveillance or high-risk conditions 2
  • Administer mucolytic/defoaming agents (simethicone, N-acetylcysteine, or pronase) 10-30 minutes before the procedure to optimize mucosal visualization 1
  • Complete safety checklist and obtain informed consent before starting 2

Endoscopist Qualifications:

  • Only endoscopists with appropriate training and relevant competencies should perform independent EGD 1, 2
  • Maintain proficiency by performing minimum 100 EGDs annually 1, 2

During the Procedure

Technical Standards:

  • Use high-definition video endoscopy systems with image capture and biopsy capabilities 2
  • Achieve adequate mucosal visualization through air insufflation, aspiration, and mucosal cleansing techniques 1
  • Document quality of mucosal visualization using a validated scale 1

Systematic Examination:

  • Begin after intubating the upper esophageal sphincter, advance to distal duodenum, then perform careful withdrawal and inspection 1
  • Critical finding: Endoscopists spending >7 minutes on average have a 3-fold increase in diagnosing gastric cancer and dysplasia compared to those taking <7 minutes 1
  • Photo-document 8 anatomical landmarks as recommended by ESGE guidelines 1

Biopsy Protocols by Anatomical Location

Esophagus:

  • Do NOT obtain routine biopsies of normal-appearing esophagus or GE junction in patients with dyspepsia alone, regardless of immune status 1
  • For Barrett's esophagus: Use Prague classification and Seattle protocol (quadrantic biopsies at 2 cm intervals) 2
  • For suspected eosinophilic esophagitis: Take biopsies from two different esophageal regions in patients with dysphagia/food bolus obstruction 1, 2
  • For grade D or atypical esophagitis/ulcers: Biopsy and re-evaluate after 4-6 weeks of PPI therapy 1, 2
  • For strictures: Biopsy before dilatation to exclude malignancy and eosinophilic esophagitis 2

Stomach:

  • Obtain routine biopsies from normal-appearing gastric body and antrum for H. pylori detection if infection status is unknown (both immunocompetent and immunocompromised patients) 1
  • Use 5-biopsy Sydney System with all specimens in the same jar 1
  • Do NOT obtain automatic special staining unless clinically indicated 1
  • For gastric ulcers: Biopsy and re-evaluate after 6-8 weeks of treatment including H. pylori eradication 1, 2
  • For gastric atrophy/intestinal metaplasia: Take separate biopsies from antrum and body 1, 2
  • For gastric polyps: Record number, size, location, morphology and take representative biopsies 1, 2
  • For suspected malignancy: Take minimum 6 biopsies with photo-documentation 2

Duodenum:

  • Do NOT obtain routine biopsies of normal-appearing duodenum for celiac disease in patients with dyspepsia alone without signs/symptoms of increased celiac risk 1
  • For suspected celiac disease: Take minimum 4 biopsies from second part of duodenum including duodenal bulb 1, 2
  • For immunocompromised patients: Consider biopsies for GVHD (post-transplant) and opportunistic infections 1
  • For iron deficiency anemia: Take duodenal specimens if celiac serology is positive or unmeasured 1, 2

Lesion Documentation

When lesions are identified:

  • Describe morphology using Paris classification 1
  • Document anatomical location precisely 1
  • Obtain photo-documentation 1
  • Take targeted biopsies as appropriate 1

Sedation Considerations

  • Adhere to safe sedation guidelines with age and comorbidities in mind 1
  • Intravenous sedation and topical anesthetic throat spray can be used together if needed, but exercise caution in aspiration-risk patients 1
  • Document any requirement for naloxone, flumazenil, or ventilation due to oversedation 1

Post-Procedure Checklist

Before patient leaves room:

  • Confirm number and correct labeling of histological samples 1
  • Document sedation/analgesia doses 1
  • Provide specific postprocedure advice 1
  • Arrange follow-up as needed 1
  • Ensure method for processing histological results is in place 2

Safety Profile

  • Overall perforation risk is 0.033% (33 per 100,000 procedures) 3
  • Perforation incidence is similar whether interventional procedures are performed or not (0.040% vs 0.029%) 3
  • Mortality after perforation is 17% with 40% morbidity 3
  • Most common perforation sites: esophagus (51%), duodenum (32%), jejunum (6%) 3

Common Pitfalls to Avoid

  • Rushing the examination: Taking <7 minutes significantly reduces cancer detection rates 1
  • Inadequate mucosal visualization: Failure to use mucolytics and proper cleansing techniques leads to missed lesions 1
  • Not following standardized biopsy protocols: Missing Seattle protocol for Barrett's or Sydney System for H. pylori detection 2
  • Failing to re-evaluate gastric ulcers: Can result in missed malignancy 1, 2
  • Obtaining unnecessary biopsies: Routine esophageal biopsies in normal-appearing mucosa with dyspepsia alone are not indicated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for Performing Oesophagogastroduodenoscopy (OGD) with Biopsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.